From the Clinical to the Bench: Exploring the Insulin Modulation Effects of Tacrolimus and Belatacept

Calcineurin inhibitors (CNIs) are critical in preventing rejection posttransplantation but pose an increased risk of post-transplant diabetes (PTD). Recent studies show that late conversion from CNIs to belatacept, a costimulation blocker, improves HbA1c in kidney transplant recipients with PTD or d...

Full description

Bibliographic Details
Published in:	Cell Transplantation
Main Authors:	Quentin Perrier, Cécile Cottet-Rouselle, Marine de-Beaumont, Johan Noble, Sandrine Lablanche
Format:	Article
Language:	English
Published:	SAGE Publishing 2024-04-01
Online Access:	https://doi.org/10.1177/09636897241246577

Similar Items

Tacrolimus to belatacept conversion in proteinuric kidney transplant recipients
by: Orhan Efe, et al.
Published: (2024-12-01)

Diabetes in spotlight: current knowledge and perspectives of photobiomodulation utilization
by: Quentin Perrier, et al.
Published: (2024-03-01)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
by: Marieke van der Zwan, MD, et al.
Published: (2019-01-01)

Pilot Analysis of Late Conversion to Belatacept in Kidney Transplant Recipients for Biopsy-Proven Chronic Tacrolimus Toxicity
by: Shruti Gupta, et al.
Published: (2018-01-01)

Belatacept in Kidney Transplantation: Reflecting on the Past, Shaping the Future
by: Johan Noble, et al.
Published: (2025-05-01)

WCN24-2548 SHORT-TERM OUTCOMES WITH NO TAPERING TACROLIMUS TO BELATACEPT CONVERSION IN RENAL TRANSPLANT RECIPIENTS (RTRs)
by: Adela Mattiazzi, et al.
Published: (2024-04-01)

Conversion to belatacept after lung transplantation: Report of 10 cases.
by: Olivier Brugière, et al.
Published: (2023-01-01)

Conversion to belatacept after lung transplantation: Report of 10 cases
by: Olivier Brugière, et al.
Published: (2023-01-01)

BELATACEPT IN RENAL TRANSPLANTATION
by: A. I. Sushkov, et al.
Published: (2013-03-01)

A case report of a lung transplant recipient receiving belatacept in combination with low dose tacrolimus complicated by progressive multifocal leukoencephalopathy
by: Vahdatpour C, et al.
Published: (2024-01-01)

The use of belatacept in kidney transplantation
by: N. N. Babenko, et al.
Published: (2018-09-01)

A Case of Pneumocystis jirovecii Pneumonia under Belatacept and Everolimus: Benefit-Risk Balance between Renal Allograft Function and Infection
by: Quentin Perrier, et al.
Published: (2021-01-01)

Similar Efficacy in Belatacept-Converted Kidney Transplant Recipients With Steroid-Avoiding Regimen
by: Nathalie Chavarot, et al.
Published: (2025-03-01)

Belatacept for Maintenance Immunosuppression in Lung Transplantation
by: Christine Hui PharmD, et al.
Published: (2014-06-01)

Switch to belatacept in kidney graft recipients
by: María O. López-Oliva, et al.
Published: (2017-09-01)

Belatacept Removal by Plasmapheresis: Dose Adjustments and Clinical Recommendations
by: Nicole K. Wilson, PharmD, MS, BCTXP, et al.
Published: (2024-08-01)

Belatacept in kidney transplantation - past and future perspectives
by: Zaki Siddiqui, et al.

Ex Vivo Alloanergization with Belatacept: A Strategy to Selectively Modulate Alloresponses after Transplantation
by: Jeff K. Davies, et al.
Published: (2012-09-01)

Long-term safety of photobiomodulation exposure to beta cell line and rat islets in vitro and in vivo
by: Quentin Perrier, et al.
Published: (2024-11-01)

CD28 Family and Chronic Rejection: “To Belatacept...and Beyond!”
by: Marcos V. Silva, et al.
Published: (2012-01-01)

WCN25-3049 BELATACEPT -THE NEED OF THE HOUR IN INDIA !
by: Jatin Kothari, et al.
Published: (2025-02-01)

Belatacept in kidney transplant patients with systemic lupus erythematosus
by: Anca Askanase, et al.
Published: (2019-12-01)

Belatacept and mediastinal histoplasmosis in a kidney transplant patient
by: Hernán Trimarchi, et al.
Published: (2016-04-01)

Improved Glucose Tolerance in a Kidney Transplant Recipient With Type 2 Diabetes Mellitus After Switching From Tacrolimus To Belatacept: A Case Report and Review of Potential Mechanisms
by: Gretchen N. de Graav, MD, PhD, et al.
Published: (2018-03-01)

Adenosine as a modulator of human islet function and hypoxic tolerance
by: Quentin Perrier, et al.
Published: (2026-06-01)

From bench to bed: deep insights the tacrolimus-induced diabetes and gut microbiota dysbiosis
by: Yuting Han, et al.
Published: (2025-08-01)

An exploration of markers of microvascular dysfunction in kidney transplant recipients randomized to belatacept: no clinical impact of CNIs on endothelial function
by: Edwin O. W. Bredewold, et al.
Published: (2026-06-01)

Improved Tacrolimus Therapeutic Drug Monitoring in Kidney Transplantation: Optimizing an Old Drug Prescription
by: Johan Noble, et al.
Published: (2025-05-01)

Evaluation of Torque Teno Virus DNA Load as a Predictive Biomarker in Kidney Transplant Recipients Converted from Calcineurin Inhibitors to Belatacept
by: Lara Cabezas, et al.
Published: (2024-06-01)

Belatacept in Pancreas Transplantation: Promising Insights From a Cohort Series
by: Christophe Masset, et al.
Published: (2024-04-01)

Belatacept Rescue Therapy in the Early Period After Simultaneous Kidney-Pancreas Transplantation
by: Laure Esposito, et al.
Published: (2024-04-01)

One-Year Outcomes After Belatacept Conversion in Adolescent Kidney Transplant Recipients
by: Charlotte Duneton, et al.
Published: (2025-06-01)

Belatacept-based immunosuppression in heart transplant recipients: A single center experience
by: Wairimu Magua, PhD, MS, et al.
Published: (2025-08-01)

Belatacept inhibit human B cell germinal center development in immunodeficient mice
by: Chloé Samson, et al.
Published: (2023-08-01)

Belatacept and regulatory T cells in transplantation: synergistic strategies for immune tolerance and graft survival
by: Gil-Ran Kim, et al.
Published: (2024-12-01)

Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction
by: Heather S Snyder, et al.
Published: (2016-10-01)

Interplay of Belatacept Immunosuppression and Maribavir Antiviral Activity in Recurrent CMV Viremia: Clinical Implications and Literature Review
by: Imran Gani, et al.
Published: (2025-04-01)

Belatacept Conversion in Adolescent Kidney Transplant Recipients: A Solution for the Critical Challenge of Adherence?
by: Dominique Bertrand
Published: (2025-06-01)

Safety profile of belatacept in a real-life setting: disproportionality analysis of the WHO pharmacovigilance database
by: Alexandre O. Gérard, et al.
Published: (2025-08-01)

Beneficial Effect of Conversion to Belatacept in Kidney-Transplant Patients with a Low Glomerular-Filtration Rate
by: Julie Belliere, et al.
Published: (2014-01-01)